Research/News - 2012

Risk of HIV Among Women Injection Drug Users

Jul 31, 2012

Prevention research has not examined closely enough the social and structural systems of women injection drug users that put them at high risk for not only HIV but Hepatitis C (HCV) and other sexually transmitted infections (STIs). Prevention strategies for these women... Read More

FDA Approves Truvada for PrEP

Jul 29, 2012

The FDA released a statement that they are changing the approved uses of emtricitabine/tenofovir (brand name Truvada) to include use in prevention of HIV transmission between partners where one partner is HIV-negative and the other partner is HIV-positive. This is only to... Read More

Hotline Presents Posters at AIDS 2012 in Washington DC

Jul 24, 2012

The Hotline presented two posters at the XIX International AIDS Conference (AIDS 2012) in Washington DC. The Hotline's posters were both presented as poster exhibitions in the exhibition hall at the convention center. One poster described Illinois' effort to have an AIDS-... Read More

IL Adolescent Hotline Goes Live

Jul 18, 2012

The Chicago Department of Public Health (CDPH), Ann & Robert H. Lurie Children's Hospital of Chicago (Lurie Children's), the Center on Halsted, the Division of Adolescent and Young Adult Medicine at Stroger Hospital, and University of Chicago Medicine announced the... Read More

Adding Nevirapine Halves Newborn Transmission Rate

Jun 24, 2012

Findings recently published in the New England Journal of Medicine found that adding nevirapine to the standard zidovudine prophylactic regimen given to newborns of women diagnosed with HIV shortly before or during labor halves the risk of maternal-to-child transmission of... Read More

Premature delivery and PI-based ARVs

Apr 05, 2012

Researchers from the French Perinatal Cohort study found that women who began ritonavir-boosted protease inhibitor threapy to treat HIV during pregnancy were more likely to have a premature delivery than those on other combination therapies and twice as likely to have a... Read More

HAART During Pregnancy for Undetectable Viral Load

Mar 29, 2012

Researchers in the United Kingdom found that HAART was most effective in achieving undetectable HIV viral loads at delivery when initiated by 20.4 weeks gestation in those women with initial viral loads >10,000 copies/ml and as late as 26.3 weeks gestation in women with... Read More

HIV/AIDS and Childbearing Hispanics/Latinas

Mar 29, 2012

Hispanic/Latina women have an overall lower median age than all other races combined as well as the highest birth rate. Additionally, they have a much higher rate of HIV/AIDS than non-Hispanic white women. Due to a variety of socioeconomic factors, Hispanic/Latina women... Read More

HIV-infected Women and Childbearing in Brazil and the US

Mar 29, 2012

Researchers surveyed HIV-positive women of childbearing age in Rio de Janiero, Brazil and Baltimore, MD regarding childbearing intentions and discussions with medical providers. Despite the fact that between one-third and one-half of women indicated a desire to have... Read More

Seroconversion During Late Pregnancy and Perinatal HIV Transmission

Mar 29, 2012

Using mathematical modeling and perinatal HIV transmission rates and feeding practices in South Africa, researchers determined that a significant amount of pediatric HIV is the result of transmission during late pregnancy or breastfeeding from mothers that seroconverted... Read More